Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Metabolism and kinetics of the hypoglycemic agent glipizide in man--comparison with glibenclamide.

× No keyword cloud information.

20 in total

Review 1. Effect of diabetes mellitus on pharmacokinetic and pharmacodynamic properties of drugs.

Authors: Miroslav Dostalek; Fatemeh Akhlaghi; Martina Puzanovova
Journal: Clin Pharmacokinet Date: 2012-08-01 Impact factor: 6.447

Review 2. Effect of genetic polymorphisms in cytochrome p450 (CYP) 2C9 and CYP2C8 on the pharmacokinetics of oral antidiabetic drugs: clinical relevance.

Authors: Julia Kirchheiner; Ivar Roots; Mark Goldammer; Bernd Rosenkranz; Jürgen Brockmöller
Journal: Clin Pharmacokinet Date: 2005 Impact factor: 6.447

3. Effect of oral verapamil on glibenclamide stimulated insulin secretion.

Authors: C G Semple; C Omile; K D Buchanan; G H Beastall; K R Paterson
Journal: Br J Clin Pharmacol Date: 1986-08 Impact factor: 4.335

4. The effects of CYP2C9 and CYP2C19 genetic polymorphisms on the pharmacokinetics and pharmacodynamics of glipizide in Chinese subjects.

Authors: Bo Tan; Yi-Fan Zhang; Xiao-Yan Chen; Xiao-Hua Zhao; Guo-Xin Li; Da-Fang Zhong
Journal: Eur J Clin Pharmacol Date: 2009-10-22 Impact factor: 2.953

Metabolism and kinetics of the hypoglycemic agent glipizide in man--comparison with glibenclamide.

Review 1. Effect of diabetes mellitus on pharmacokinetic and pharmacodynamic properties of drugs.

Review 2. Effect of genetic polymorphisms in cytochrome p450 (CYP) 2C9 and CYP2C8 on the pharmacokinetics of oral antidiabetic drugs: clinical relevance.

3. Effect of oral verapamil on glibenclamide stimulated insulin secretion.

4. The effects of CYP2C9 and CYP2C19 genetic polymorphisms on the pharmacokinetics and pharmacodynamics of glipizide in Chinese subjects.

5. Correlations between in vitro dissolution, in vivo bioavailability and hypoglycaemic effect of oral glibenclamide.

6. Effect of guar gum on glipizide absorption in man.

7. Bioavailability of immediate- and extended-release formulations of glipizide in healthy male volunteers.

8. Behaviour of glibenclamide on repeated administration to diabetic patients.

9. Comparison of the pharmacokinetics of glipizide and glibenclamide in man.

Review 10. Pharmacokinetics of oral antihyperglycaemic agents in patients with renal insufficiency.